Women with pathologic variants of different breast cancer genes, such as BRCA1/2, TP53 and PTEN, have a higher lifetime risk of developing breast cancer in comparison to the overall population (2, –4), and are, depending on the risk profile, recommended annual surveillance or prophylactic surgery (1). The gene discussed is TP53; the disease is breast carcinoma.